Genetic and clinical features of multiple endocrine neoplasia types 1 and 2

Journal of Oncology

Volumn , Issue , 2012, Pages

  Romei, C ^a   Pardi, E ^a   Cetani, F ^a   Elisei, R ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AXITINIB; CABOZANTINIB; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GEFITINIB; HISTONE DEACETYLASE; IMATINIB; METHIONINE; MIXED LINEAGE LEUKEMIA PROTEIN; MOTESANIB; SORAFENIB; SUNITINIB; TRANSCRIPTION FACTOR EZH2; VANDETANIB;

ACROMEGALY; ADRENAL TUMOR; CANCER PROGNOSIS; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ESOPHAGOGASTRODUODENOSCOPY; FRAMESHIFT MUTATION; GASTRINOMA; GENE; GENE EXPRESSION; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HEMANGIOFIBROMA; HUMAN; HYPERGASTRINEMIA; HYPERPARATHYROIDISM; HYPOPHYSIS ADENOMA; INSULINOMA; LIPOMA; MEN 1 GENE; MICROADENOMA; MOLECULAR PATHOLOGY; MULTIPLE ENDOCRINE NEOPLASIA; NEUROFIBROMATOSIS; NONHUMAN; NONSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET CELL TUMOR; PARATHYROID ADENOMA; PARATHYROID CARCINOMA; PARATHYROID HYPERPLASIA; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PROLACTINOMA; PROPHYLAXIS; RETINOBLASTOMA; REVIEW; SCREENING; SIPPLE SYNDROME; THYMOMA; THYROID MEDULLARY CARCINOMA; THYROID TUMOR;

EID: 84870152937     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/705036     Document Type: Review

References (99)

1. Carney J. A., Familial multiple endocrine neoplasia syndromes: components, classification, and nomenclature. Journal of Internal Medicine 1998 243 6 425 432 2-s2.0-0031861882 10.1046/j.1365-2796.1998.00345.x (Pubitemid 28312237)
2. Marsh D. J., Gimm O., Multiple endocrine neoplasia: types 1 and 2. Advances in Oto-Rhino-Laryngology 2011 70 84 90 2-s2.0-79952388666 10.1159/000322479
3. Brandi M. L., Gagel R. F., Angeli A., Bilezikian J. P., Beck-Peccoz P., Bordi C., Conte-Devolx B., Falchetti A., Gheri R. G., Libroia A., Lips C. J. M., Lombardi G., Mannelli M., Pacini F., Ponder B. A. J., Raue F., Skogseid B., Tamburrano G., Thakker R. V., Thompson N. W., Tomassetti P., Tonelli F., Wells Jr.S.A., Marx S. J., Consensus: guidelines for diagnosis and therapy of MEN type 1 and type 2. Journal of Clinical Endocrinology and Metabolism 2001 86 12 5658 5671 2-s2.0-0036440553 10.1210/jc.86.12.5658 (Pubitemid 33152604)
4. Kloos R. T., Eng C., Evans D. B., Francis G. L., Gagel R. F., Gharib H., Moley J. F., Pacini F., Ringel M. D., Schlumberger M., Wells S. A., Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 2009 19 6 565 612 2-s2.0-67749130797
5. Wohllk N., Schweizer H., Erlic Z., Schmid K. W., Walz M. K., Raue F., Neumann H. P. H., Multiple endocrine neoplasia type 2. Best Practice and Research 2010 24 3 371 387 2-s2.0-77956581017 10.1016/j.beem.2010.02.001
6. Carney J. A., Familial multiple endocrine neoplasia: the first 100 years. American Journal of Surgical Pathology 2005 29 2 254 274 2-s2.0-12844251289 10.1097/01.pas.0000147402.95391.41 (Pubitemid 40170645)
7. Asgharian B., Chen Y. J., Patronas N. J., Peghini P. L., Reynolds J. C., Vortmeyer A., Zhuang Z., Venzon D. J., Gibril F., Jensen R. T., Meningiomas may be a component tumor of multiple endocrine neoplasia type 1. Clinical Cancer Research 2004 10 3 869 880 2-s2.0-10744230159 10.1158/1078-0432.CCR-0938-3 (Pubitemid 38198885)
8. Asgharian B., Turner M. L., Gibril F., Entsuah L. K., Serrano J., Jensen R. T., Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1. Journal of Clinical Endocrinology and Metabolism 2004 89 11 5328 5336 2-s2.0-8744243279 10.1210/jc.2004-0218 (Pubitemid 39518405)
9. Darling T. N., Skarulis M. C., Steinberg S. M., Marx S. J., Spiegel A. M., Turner M., Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Archives of Dermatology 1997 133 7 853 857 2-s2.0-0030748358 (Pubitemid 27337545)
10. del Pozo C., García-Pascual L., Balsells M., Barahona M., Veloso E., González C., Anglada-Barceló J., Parathyroid carcinoma in multiple endocrine neoplasia type 1. case report and review of the literature. Hormones 2011 10 4 326 331 2-s2.0-84856659092
11. Cetani F., Pardi E., Borsari S., Marcocci C., Molecular pathogenesis of primary hyperparathyroidism. Journal of Endocrinological Investigation 2011 34 7, supplement 35 39 2-s2.0-84861658606
12. Pieterman C. R. C., Van Hulsteijn L. T., Den Heijer M., Van Der Luijt R. B., Bonenkamp J. J., Hermus A. R. M. M., Rinkes I. H. M. B., Vriens M. R., Valk G. D., Primary hyperparathyroidism in MEN1 patients: A cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. Annals of Surgery 2012 255 6 1171 1178 2-s2.0-84861340925 10.1097/SLA.0b013e31824c5145
13. Eller-Vainicher C., Chiodini I., Battista C., Viti R., Mascia M. L., Massironi S., Peracchi M., D'Agruma L., Minisola S., Corbetta S., Cole D. E. C., Spada A., Scillitani A., Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity. Journal of Bone and Mineral Research 2009 24 8 1404 1410 2-s2.0-68949099631 10.1359/jbmr.090304
14. Romei C., Mariotti S., Fugazzola L., Taccaliti A., Pacini F., Opocher G., Mian C., Castellano M., Uberti E. D., Ceccherini I., Cremonini N., Seregni E., Orlandi F., Ferolla P., Puxeddu E., Giorgino F., Colao A., Loli P., Bondi F., Cosci B., Bottici V., Cappai A., Pinna G., Persani L., Uberta V., Boscaro M., Castagna M. G., Cappelli C., Zatelli M. C., Faggiano A., Francia G., Brandi M. L., Falchetti A., Pinchera A., Elisei R., Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. European Journal of Endocrinology 2010 163 2 301 308 2-s2.0-78649895938 10.1530/EJE-10-0333
15. Frank-Raue K., Höppner W., Frilling A., Kotzerke J., Dralle H., Haase R., Mann K., Seif F., Kirchner R., Rendl J., Deckart H. F., Ritter M. M., Hampel R., Klempa J., Scholz G. H., Raue F., Bogner U., Brabant G., Grussendorf M., Hartenstein C. H., Heidemann P., Hensen J., Dörr A. G., Höhne T., Hörnig-Franz I., Hüfner M., Kre J., Langer H. J., Lottermoser K., Schweikert H. U., Kusterer K., Menken U., Mercier J., Oelkers W., Sauer J., Simon D., Starrach G., Ziegler R., Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. Journal of Clinical Endocrinology and Metabolism 1996 81 5 1780 1783 2-s2.0-9344234978 10.1210/jc.81.5.1780 (Pubitemid 26152463)
16. Machens A., Niccoli-Sire P., Hoegel J., Frank-Raue K., Van Vroonhoven T. J., Roeher H. D., Wahl R. A., Lamesch P., Raue F., Conte-Devolx B., Dralle H., Early malignant progression of hereditary medullary thyroid cancer. New England Journal of Medicine 2003 349 16 1517 1525 2-s2.0-0141940150 10.1056/NEJMoa012915 (Pubitemid 37255037)
17. Schussheim D. H., Skarulis M. C., Agarwal S. K., Simonds W. F., Burns A. L., Spiegel A. M., Marx S. J., Multiple endocrine neoplasia type 1: new clinical and basic findings. Trends in Endocrinology and Metabolism 2001 12 4 173 178 2-s2.0-0035347317 (Pubitemid 33713559)
18. Tonelli F., Giudici F., Fratini G., Brandi M. L., Pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: review of literature. Endocrine Practice 2011 17 supplement 3 33 40 2-s2.0-80054032547 10.4158/EP10376.RA
19. Delemer B., MEN1 and pituitary adenomas. Annales d'Endocrinologie 2012 73 2 59 61 2-s2.0-84861347431 10.1016/j.ando.2012.03.038
20. Syro L. V., Scheithauer B. W., Kovacs K., Toledo R. A., Londoño F. J., Ortiz L. D., Rotondo F., Horvath E., Uribe H., Pituitary tumors in patients with MEN1 syndrome. Clinics 2012 67 supplement 43 48 2-s2.0-84864365548 10.6061/clinics/2012(Sup01)09
21. Schaefer S., Shipotko M., Meyer S., Ivan D., Klose K. J., Waldmann J., Langer P., Kann P. H., Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: An endoscopic ultrasound imaging study. European Journal of Endocrinology 2008 158 5 699 704 2-s2.0-43149106664 10.1530/EJE-07-0635 (Pubitemid 351639608)
22. Thakker R. V., Multiple endocrine neoplasia type 1 (MEN1). Best Practice & Research 2010 24 3 355 370
23. Goudet P., Bonithon-Kopp C., Murat A., Ruszniewski P., Niccoli P., Ménégaux F., Chabrier G., Borson-Chazot F., Tabarin A., Bouchard P., Cadiot G., Beckers A., Guilhem I., Chabre O., Caron P., Du Boullay H., Verges B., Cardot-Bauters C., Gender-related differences in MEN1 lesion occurrence and diagnosis: A cohort study of 734 cases from the Groupe d'étude des Tumeurs Endocrines. European Journal of Endocrinology 2011 165 1 97 105 2-s2.0-79959436575 10.1530/EJE-10-0950
24. Miedlich S., Lohmann T., Schneyer U., Lamesch P., Paschke R., Familial isolated primary hyperparathyroidism-A multiple endocrine neoplasia type 1 variant? European Journal of Endocrinology 2001 145 2 155 160 2-s2.0-0034904731 (Pubitemid 32707600)
25. Larsson C., Skogseid B., Oberg K., Nakamura Y., Nordenskjold M., Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988 332 6159 85 87 2-s2.0-0023828816 (Pubitemid 18083554)
26. Chandrasekharappa S. C., Guru S. C., Manickam P., Olufemi S. E., Collins F. S., Emmert-Buck M. R., Debelenko L. V., Zhuang Z., Lubensky I. A., Liotta L. A., Crabtree J. S., Wang Y., Roe B. A., Weisemann J., Boguski M. S., Agarwal S. K., Kester M. B., Kim Y. S., Heppner C., Dong Q., Spiegel A. M., Burns A. L., Marx S. J., Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997 276 5311 404 406 2-s2.0-0030963446 10.1126/science.276.5311.404 (Pubitemid 27180699)
27. Knudson A. G., Two genetic hits (more or less) to cancer. Nature Reviews Cancer 2001 1 2 157 162 2-s2.0-0035522894 (Pubitemid 33741891)
28. Balogh K., Patócs A., Hunyady L., Rácz K., Menin dynamics and functional insight: take your partners. Molecular and Cellular Endocrinology 2010 326 1-2 80 84 2-s2.0-77955314155 10.1016/j.mce.2010.04.011
29. Wu T., Hua X., Menin represses tumorigenesis via repressing cell proliferation. American Journal of Cancer Research 2011 1 6 726 39
30. Huang J., Gurung B., Wan B., Matkar S., Veniaminova N. A., Wan K., Merchant J. L., Hua X., Lei M., The same pocket in menin binds both MLL and JUND but has opposite effects on transcription. Nature 2012 482 7386 542 546 2-s2.0-84862777931 10.1038/nature10806
31. Lemos M. C., Thakker R. V., Multiple endocrine neoplasia type 1 (MEN1): Analysis of 1336 mutations reported in the first decade following identification of the gene. Human Mutation 2008 29 1 22 32 2-s2.0-38149112594 10.1002/humu.20605
32. Crabtree J. S., Scacheri P. C., Ward J. M., Garrett-Beal L., Emmert-Buck M. R., Edgemon K. A., Lorang D., Libutti S. K., Chandrasekharappa S. C., Marx S. J., Spiegel A. M., Collins F. S., A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proceedings of the National Academy of Sciences of the United States of America 2001 98 3 1118 1123 2-s2.0-0035970092 10.1073/pnas.98.3.1118 (Pubitemid 32121196)
33. Bertolino P., Tong W. M., Galendo D., Wang Z. Q., Zhang C. X., Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1. Molecular Endocrinology 2003 17 9 1880 1892 2-s2.0-0042835760 10.1210/me.2003-0154 (Pubitemid 37072302)
34. Crabtree J. S., Scacheri P. C., Ward J. M., McNally S. R., Swain G. P., Montagna C., Hager J. H., Hanahan D., Edlund H., Magnuson M. A., Garrett-Beal L., Burns A. L., Ried T., Chandrasekharappa S. C., Marx S. J., Spiegel A. M., Collins F. S., Of mice and MEN1: insulinomas in a conditional mouse knockout. Molecular and Cellular Biology 2003 23 17 6075 6085 2-s2.0-0041970059 10.1128/MCB.23.17.6075-6085.2003 (Pubitemid 37013087)
35. Lips C. J., Dreijerink K. M., Höppener J. W., Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype-phenotype correlation. Clinics 2012 67 supplement 49 56 2-s2.0-79952733180 10.6061/clinics/2012(Sup01)10
36. Olufemi S.-E., Green J. S., Manickam P., Guru S. C., Agarwal S. K., Kester M. B., Dong Q., Burns A. L., Spiegel A. M., Marx S. J., Collins F. S., Chandrasekharappa S. C., Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1(Burin)) in four kindreds from Newfoundland. Human Mutation 1998 11 4 264 269 2-s2.0-7144229389 10.1002/(SICI)1098-1004(1998)11:4264::AID-HUMU2>3.0.CO;2-V (Pubitemid 28177866)
37. Kong C., Ellard S., Johnston C., Farid N. R., Multiple endocrine neoplasia type 1Burin from Mauritius: A novel MEN 1 mutation. Journal of Endocrinological Investigation 2001 24 10 806 810 2-s2.0-0035194573 (Pubitemid 33120976)
38. Lourenco J. D. M., Toledo R. A., Mackowiak I. I., Coutinho F. L., Cavalcanti M. G., Correia-Deur J. E. M., Montenegro F., Siqueira S. A. C., Margarido L. C., Machado M. C., Toledo S. P. A., Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile. European Journal of Endocrinology 2008 159 3 259 274 2-s2.0-53249109898 10.1530/EJE-08-0153
39. Cetani F., Pardi E., Giovannetti A., Vignali E., Borsari S., Golia F., Cianferotti L., Viacava P., Miccoli P., Gasperi M., Pinchera A., Marcocci C., Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism. Clinical Endocrinology 2002 56 4 457 464 2-s2.0-0036228986 10.1046/j.1365-2265.2002.01502.x (Pubitemid 34429620)
40. Pellegata N. S., Quintanilla-Martinez L., Siggelkow H., Samson E., Bink K., Höfler H., Fend F., Graw J., Atkinson M. J., Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proceedings of the National Academy of Sciences of the United States of America 2006 103 42 15558 15563 2-s2.0-33750361636 10.1073/pnas.0603877103 (Pubitemid 44625631)
41. Pellegata N. S., MENX. Annales d'Endocrinologie 2012 73 2 65 70 2-s2.0-84863896501 10.1016/j.ando.2012.04.001
42. Molatore S., Pellegata N. S., The MENX syndrome and p27: relationships with multiple endocrine neoplasia. Progress in Brain Research 2010 182 295 320 2-s2.0-77956634043
43. Marinoni I., Pellegata N. S., p27kip1: A new multiple endocrine neoplasia gene? Neuroendocrinology 2011 93 1 19 28 2-s2.0-79951672207 10.1159/000320366
44. Nilubol N., Weinstein L., Simonds W. F., Jensen R. T., Phan G. Q., Hughes M. S., Libutti S. K., Marx S., Kebebew E., Preoperative localizing studies for initial parathyroidectomy in MEN1 syndrome: is there any benefit? World Journal of Surgery 2012 36 6 1368 1374 2-s2.0-84864289772 10.1007/s00268-012-1451-1
45. Vergès B., Boureille F., Goudet P., Murat A., Beckers A., Sassolas G., Cougard P., Chambe B., Montvernay C., Calender A., Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. Journal of Clinical Endocrinology and Metabolism 2002 87 2 457 465 2-s2.0-18244392974 10.1210/jc.87.2.457 (Pubitemid 34158204)
46. Barbe C., Murat A., Dupas B., Ruszniewski P., Tabarin A., Vullierme M.-P., Penfornis A., Rohmer V., Baudin E., Le Rhun M., Gaye D., Marcus C., Cadiot G., Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumours in multiple endocrine neoplasia type 1. Digestive and Liver Disease 2012 44 3 228 234 2-s2.0-84856586635 10.1016/j.dld.2011.09.014
47. Thakker R. V., Newey P. J., Walls G. V., Bilezikian J., Dralle H., Ebeling P. R., Melmed S., Sakurai A., Tonelli F., Brandi M. L., Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). Journal of Clinical Endocrinology and Metabolism 2012 97 9 2990 3011 2-s2.0-84860916286 10.1210/jc.2012-1230
48. Stratakis C. A., Schussheim D. H., Freedman S. M., Keil M. F., Pack S. D., Agarwal S. K., Skarulis M. C., Weil R. J., Lubensky I. A., Zhuang Z., Oldfield E. H., Marx S. J., Pituitary macroadenoma in a 5-year-old: An early expression of multiple endocrine neoplasia type 1. Journal of Clinical Endocrinology and Metabolism 2000 85 12 4776 4780 2-s2.0-17744393832 10.1210/jc.85.12.4776 (Pubitemid 32157665)
49. Carling T., Udelsman R., Parathyroid surgery in familial hyperparathyroid disorders. Journal of Internal Medicine 2005 257 1 27 37 2-s2.0-12344296364 10.1111/j.1365-2796.2004.01428.x (Pubitemid 40129124)
50. Waldmann J., López C. L., Langer P., Rothmund M., Bartsch D. K., Surgery for multiple endocrine neoplasia type 1-Associated primary hyperparathyroidism. British Journal of Surgery 2010 97 10 1528 1534 2-s2.0-77957013502 10.1002/bjs.7154
51. Elaraj D. M., Skarulis M. C., Libutti S. K., Norton J. A., Bartlett D. L., Pingpank J. F., Gibril F., Weinstein L. S., Jensen R. T., Marx S. J., Alexander H. R., Lairmore T. C., Rosen I. B., Shaha A. R., Dralle H., Prinz R. A., Weber C. J., Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery 2003 134 6 858 865 2-s2.0-10744226310 10.1016/S0039-6060(03)00406-9 (Pubitemid 38010729)
52. Tonelli F., Spini S., Tommasi M., Gabbrielli G., Amorosi A., Brocchi A., Brandi M. L., Intraoperative parathormone measurement in patients with multiple endocrine neoplasia type I syndrome and hyperparathyroidism. World Journal of Surgery 2000 24 5 556 563 2-s2.0-0034079151 10.1007/s002689910091 (Pubitemid 30210845)
53. Tonelli F., Marcucci T., Fratini G., Tommasi M. S., Falchetti A., Brandi M. L., Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1? Annals of Surgery 2007 246 6 1075 1082 2-s2.0-36549002670 10.1097/SLA.0b013e31811f4467 (Pubitemid 350179202)
54. Dickson P. V., Rich T. A., Xing Y., Cote G. J., Wang H., Perrier N. D., Evans D. B., Lee J. E., Grubbs E. G., Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important. Surgery 2011 150 6 1143 1152 2-s2.0-82755182448 10.1016/j.surg.2011.09.028
55. Triponez F., Dosseh D., Goudet P., Cougard P., Bauters C., Murat A., Cadiot G., Niccoli-Sire P., Chayvialle J. A., Calender A., Proye C. A. G., Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas. Annals of Surgery 2006 243 2 265 272 2-s2.0-31844446111 10.1097/01.sla.0000197715.96762.68 (Pubitemid 43185447)
56. Öberg K., Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches. Current Opinion in Oncology 2012 24 4 433 440 2-s2.0-84862135843 10.1097/CCO.0b013e328353d7ba
57. Germain A., Klein M., Brunaud L., Surgical management of adrenal tumors. Journal of Visceral Surgery 2011 148 4 e250 e261
58. Goudet P., Murat A., Binquet C., Cardot-Bauters C., Costa A., Ruszniewski P., Niccoli P., Ménégaux F., Chabrier G., Borson-Chazot F., Tabarin A., Bouchard P., Delemer B., Beckers A., Bonithon-Kopp C., Risk factors and causes of death in men1 disease. A gte (groupe d'etude des tumeurs endocrines) cohort study among 758 patients. World Journal of Surgery 2010 34 2 249 255 2-s2.0-77949266483 10.1007/s00268-009-0290-1
59. Neumann H. P. H., Vortmeyer A., Schmidt D., Werner M., Erlic Z., Cascon A., Bausch B., Januszewicz A., Eng C., Brief report: evidence of MEN-2 in the original description of classic pheochromocytoma. New England Journal of Medicine 2007 357 13 1311 1315 2-s2.0-34748870667 10.1056/NEJMoa071407 (Pubitemid 47481453)
60. Sipple J. H., Multiple endocrine neoplasia type 2 syndromes: historical perspectives. Henry Ford Hospital Medical Journal 1984 32 4 219 222 2-s2.0-0021675239 (Pubitemid 15110218)
61. Keiser H. R., Beaven M. A., Doppman J., Wells S., Buja L. M., Sipple's syndrome: medullary thyroid carcinoma, pheochromocytoma, and parathyroid disease. Studies in a large family. NIH conference. Annals of Internal Medicine 1973 78 4 561 579 2-s2.0-0015606335
62. Steiner A. L., Goodman A. D., Powers S. R., Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2. Medicine 1968 47 5 371 409 2-s2.0-0014331669
63. Howe J. R., Norton J. A., Wells S. A., Proye C., Talpos G. B., Carty S. E., Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up. Surgery 1993 114 6 1070 1077 2-s2.0-0027136050 (Pubitemid 24004725)
64. Inabnet W. B., Caragliano P., Pertsemlidis D., Udelsman R., Lennard T., Proye C., Dralle H., Pheochromocytoma: inherited associations, bilaterality, and cortex preservation. Surgery 2000 128 6 1007 1012 2-s2.0-0033675895
65. Rodriguez J. M., Balsalobre M., Ponce J. L., Ríos A., Torregrosa N. M., Tebar J., Parrilla P., Pheochromocytoma in MEN 2A syndrome. Study of 54 patients. World Journal of Surgery 2008 32 11 2520 2526 2-s2.0-53949093476 10.1007/s00268-008-9734-2
66. Verdy M., Weber A. M., Roy C. C., Hirschsprung's disease in a family with multiple endocrine neoplasia type 2. Journal of Pediatric Gastroenterology and Nutrition 1982 1 4 603 607 2-s2.0-0020314519 (Pubitemid 13091793)
67. Verdy M. B., Cadotte M., Schurch W., A French Canadian family with multiple endocrine neoplasia type 2 syndromes. Henry Ford Hospital Medical Journal 1984 32 4 251 253 2-s2.0-0021704392 (Pubitemid 15110226)
68. Eng C., Clayton D., Schuffenecker I., Lenoir G., Cote G., Gagel R. F., Ploos Van Amstel H. K., Lips C. J. M., Nishisho I., Takai S. I., Marsh D. J., Robinson B. G., Frank-Raue K., Raue F., Xue F., Noll W. W., Romei C., Pacini F., Fink M., Niederle B., Zedenius J., Nordenskjöld M., Komminoth P., Hendy G. N., Gharib H., Thibodeau S. N., Lacroix A., Frilling A., Ponder B. A. J., Mulligan L. M., The relationship between specific ret proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: international RET mutation consortium analysis. Journal of the American Medical Association 1996 276 19 1575 1579 2-s2.0-4644256817 10.1001/jama.276.19.1575 (Pubitemid 26384740)
69. Donovan D. T., Levy M. L., Alford B. R., Wheeler T., Tschen J. A., Gagel R. F., Furst E. J., Familial cutaneous lichen amyloidosis in association with multiple endocrine neoplasia type 2A: A new variant. Henry Ford Hospital Medical Journal 1989 37 3-4 147 150 2-s2.0-0024958177 (Pubitemid 20207552)
70. Gagel R. F., Levy M. L., Donovan D. T., Alford B. R., Wheeler T., Tschen J. A., Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis. Annals of Internal Medicine 1989 111 10 802 806 2-s2.0-0024456602 (Pubitemid 19283916)
71. Cunliffe W. J., Hudgson P., Fulthorpe J. J., Black M. M., Hall R., Johnston I. D. A., Shuster S., A calcitonin-secreting medullary thyroid carcinoma associated with mucosal neuromas, marfanoid features, myopathy and pigmentation. The American Journal of Medicine 1970 48 1 120 126 2-s2.0-0014705967
72. Brauckhoff M., Machens A., Hess S., Lorenz K., Gimm O., Brauckhoff K., Sekulla C., Dralle H., Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis. Surgery 2008 144 6 1044 1051 2-s2.0-56449098562 10.1016/j.surg.2008.08.028
73. Farndon J. R., Leight G. S., Dilley W. G., Familial medullary thyroid carcinoma without associated endocrinopathies: A distinct clinical entity. British Journal of Surgery 1986 73 4 278 281 2-s2.0-0022535165 (Pubitemid 16051044)
74. Elisei R., Romei C., Cosci B., Agate L., Bottici V., Molinaro E., Sculli M., Miccoli P., Basolo F., Grasso L., Pacini F., Pinchera A., Brief report: RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. Journal of Clinical Endocrinology and Metabolism 2007 92 12 4725 4729 2-s2.0-36849056630 10.1210/jc.2007-1005 (Pubitemid 350223450)
75. Niccoli-Sire P., Murat A., Rohmer V., Franc S., Chabrier G., Baldet L., Maes B., Savagner F., Giraud S., Bezieau S., Kottler M. L., Morange S., Conte-Devolx B., Familial medullary thyroid carcinoma with noncysteine RET mutations: phenotype-genotype relationship in a large series of patients. Journal of Clinical Endocrinology and Metabolism 2001 86 8 3746 3753 2-s2.0-17944370976 10.1210/jc.86.8.3746 (Pubitemid 32755971)
76. Romei C., Cosci B., Renzini G., Bottici V., Molinaro E., Agate L., Passannanti P., Viola D., Biagini A., Basolo F., Ugolini C., Materazzi G., Pinchera A., Vitti P., Elisei R., RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC). Clinical Endocrinology 2011 74 2 241 247 2-s2.0-78651342915 10.1111/j.1365-2265.2010.03900.x
77. Cohen M. S., Moley J. F., Surgical treatment of medullary thyroid carcinoma. Journal of Internal Medicine 2003 253 6 616 626 2-s2.0-0038695856 10.1046/j.1365-2796.2003.01166.x (Pubitemid 36649093)
78. Donis-Keller H., Dou S., Chi D., Carlson K. M., Toshima K., Lairmore T. C., Howe J. R., Moley J. F., Goodfellow P., Wells S. A., Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Human Molecular Genetics 1993 2 7 851 856 2-s2.0-0027303248 (Pubitemid 23216611)
79. Mulligan L. M., Kwok J. B. J., Healey C. S., Elsdon M. J., Eng C., Gardner E., Love D. R., Mole S. E., Moore J. K., Papl L., Ponder M. A., Telenius H., Tunnacliffe A., Ponder B. A. J., Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993 363 6428 458 460 2-s2.0-0027231568 10.1038/363458a0 (Pubitemid 23179393)
80. Eng C., Smith D. P., Mulligan L. M., Nagai M. A., Healey C. S., Ponder M. A., Gardner E., Scheumann G. F. W., Jackson C. E., Tunnacliffe A., Ponder B. A. J., Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Human Molecular Genetics 1994 3 2 237 241 2-s2.0-0028006092 (Pubitemid 24060936)
81. Erdogan M. F., Gürsoy A., Özgen G., Çakir M., Bayram F., Ersoy R., Algün E., Çetinarslan B., Çomlekçi A., Kadioglu P., Bald M. K., Yetkin I., Kabalak T., Erdogan G., Ret proto-oncogene mutations in apparently sporadic Turkish medullary thyroid carcinoma patients: Turkmen study. Journal of Endocrinological Investigation 2005 28 9 806 809 2-s2.0-31544460391 (Pubitemid 43162835)
82. Eng C., Mulligan L. M., Smith D. P., Healey C. S., Frilling A., Raue F., Neumann H. P. H., Ponder M. A., Ponder B. A. J., Low frequency of germline mutations in the RET protooncogene in patients with apparently sporadic medullary thyroid carcinoma. Clinical Endocrinology 1995 43 1 123 127 2-s2.0-0029028664
83. Orgiana G., Pinna G., Camedda A., De Falco V., Santoro M., Melillo R. M., Elisei R., Romei C., Lai S., Carcassi C., Mariotti S., A new germline RET mutation apparently devoid of transforming activity serendipitously discovered in a patient with atrophic autoimmune thyroiditis and primary ovarian failure. Journal of Clinical Endocrinology and Metabolism 2004 89 10 4810 4816 2-s2.0-6344287401 10.1210/jc.2004-0365 (Pubitemid 39391411)
84. Cosci B., Vivaldi A., Romei C., Gemignani F., Landi S., Ciampi R., Tacito A., Molinaro E., Agate L., Bottici V., Cappagli V., Viola D., Piaggi P., Vitti P., Pinchera A., Elisei R., In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer. Endocrine-Related Cancer 2011 18 5 603 612 2-s2.0-80054950358 10.1530/ERC-11-0117
85. Hansford J. R., Mulligan L. M., Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. Journal of Medical Genetics 2000 37 11 817 827 2-s2.0-0033729031
86. Zbuk K. M., Eng C., Cancer phenomics: RET and PTEN as illustrative models. Nature Reviews Cancer 2007 7 1 35 45 2-s2.0-33845875992 10.1038/nrc2037 (Pubitemid 46020845)
87. Miyauchi A., Futami H., Hai N., Yokozawa T., Kuma K., Aoki N., Kosugi S., Sugano K., Yamaguchi K., Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation. Japanese Journal of Cancer Research 1999 90 1 1 5 2-s2.0-0033045514 (Pubitemid 29084304)
88. Menko F. H., Van Der Luijt R. B., De Valk I. A. J., Toorians A. W. F. T., Sepers J. M., Van Diest P. J., Lips C. J. M., Atypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918. Journal of Clinical Endocrinology and Metabolism 2002 87 1 393 397 2-s2.0-0036148536 10.1210/jc.87.1.393 (Pubitemid 34084720)
89. Frank-Raue K., Rondot S., Raue F., Molecular genetics and phenomics of RET mutations: impact on prognosis of MTC. Molecular and Cellular Endocrinology 2010 322 1-2 2 7 2-s2.0-77952877804 10.1016/j.mce.2010.01.012
90. Elisei R., Romei C., Renzini G., Bottici V., Cosci B., Molinaro E., Agate L., Cappagli V., Miccoli P., Berti P., Faviana P., Ugolini C., Basolo F., Vitti P., Pinchera A., The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 Years experience at one single center. Journal of Clinical Endocrinology and Metabolism 2012 97 2 426 435 2-s2.0-84856950356 10.1210/jc.2011-2046
91. Machens A., Hauptmann S., Dralle H., Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer. World Journal of Surgery 2007 31 10 1960 1965 2-s2.0-34548688232 10.1007/s00268-007- 9185-1 (Pubitemid 47415724)
92. Russell C. F., Van Heerden J. A., Sizemore G. W., The surgical management of medullary thyroid carcinoma. Annals of Surgery 1983 197 1 42 48 2-s2.0-0020665279 (Pubitemid 13211722)
93. Walz M. K., Alesina P. F., Single access retroperitoneoscopic adrenalectomy (SARA)-one step beyond in endocrine surgery. Langenbeck's Archives of Surgery 2009 394 3 447 450 2-s2.0-67749147456 10.1007/s00423-008-0418-z
94. Lau G. S. K., Lang B. H. H., Lo C. Y., Tso A., Garcia-Barcelo M. M., Tam P. K., Lam K. S. L., Prophylactic thyroidectomy in ethnic Chinese patients with multiple endocrine neoplasia type 2A syndrome after the introduction of genetic testing. Hong Kong Medical Journal 2009 15 5 326 331 2-s2.0-70350236903
95. Rohmer V., Vidal-Trecan G., Bourdelot A., Niccoli P., Murat A., Wemeau J. L., Borson-Chazot F., Schvartz C., Tabarin A., Chabre O., Chabrier G., Caron P., Rodien P., Schlumberger M., Baudin E., Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: A multicenter study of the Groupe Français d'Etude des Tumeurs Endocrines. Journal of Clinical Endocrinology and Metabolism 2011 96 3 E509 E518 2-s2.0-79952292850 10.1210/jc.2010-1234
96. Sherman S. I., Advances in chemotherapy of differentiated epithelial and medullary thyroid cancers. Journal of Clinical Endocrinology and Metabolism 2009 94 5 1493 1499 2-s2.0-66149148281 10.1210/jc.2008-0923
97. Sherman S. I., Cytotoxic chemotherapy for differentiated thyroid carcinoma. Clinical Oncology 2010 22 6 464 468 2-s2.0-79551598532 10.1016/j.clon.2010.03.014
98. Wells Jr. S. A., Robinson B. G., Gagel R. F., Dralle H., Fagin J. A., Santoro M., Baudin E., Elisei R., Jarzab B., Vasselli J. R., Read J., Langmuir P., Ryan A. J., Schlumberger M. J., Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: A randomized, double-blind phase III trial. Journal of Clinical Oncology 2012 30 2 134 141 2-s2.0-84863197764 10.1200/JCO.2011.35.5040
99. Gild M. L., Bullock M., Robinson B. G., Clifton-Bligh R., Multikinase inhibitors: A new option for the treatment of thyroid cancer. Nature Reviews Endocrinology 2011 7 10 617 624 2-s2.0-79955042546 10.1038/nrendo.2011.141